Effects of Ciprofol Anesthesia on Learning and Memory Function and Antidepressant Effects of ECT in Depressive Patients - Trial NCT05266560
Access comprehensive clinical trial information for NCT05266560 through Pure Global AI's free database. This Early Phase 1 trial is sponsored by First Affiliated Hospital of Chongqing Medical University and is currently Not yet recruiting. The study focuses on Depressive Disorder. Target enrollment is 390 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
First Affiliated Hospital of Chongqing Medical University
Timeline & Enrollment
Early Phase 1
Mar 01, 2022
Dec 31, 2024
Primary Outcome
Cognitive impairment rate within 24 hours after the whole ECT course
Summary
In this clinical study, propofol was used as the positive control, and a randomized
 controlled trial design was used to observe the effects of ciprofol anesthesia on learning
 and memory function and antidepressant efficacy in patients with ECT. A total of 390
 depressed patients who were to undergo electroconvulsive therapy were selected and randomly
 divided into two groups, namely the propofol group (n=195 cases) and the ciprofol group
 (n=195 cases). The patients in the propofol group were given propofol 1.5mg/kg +
 succinylcholine 1mg/kg, and the patients in the ciprofol group were given ciprofol 0.4mg/kg
 and succinylcholine 1mg/kg, and the patients were given electroshock after anesthesia treat.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05266560
Non-Device Trial